With the analysis among 4,148 patents, we discovered top 439 key players by total patent application. Janssen Vaccines & Prevention BV, Medicago, Inc., Vertex Pharmaceuticals, Inc. are dominant in this area. They take 8.37% of the total patent filing.
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 146
Quebec, Canada
Patent: 115
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 86
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 72
Wisconsin, United States
Patent: 67
Louisiana, United States
Patent: 66
GlaxoSmithKline Biologicals SA
Intervet International BV
Noord-Brabant, Netherlands
Patent: 58
Ticino, Switzerland
Patent: 58
With the analysis among 121 patents, we discovered top 31 start-ups by total patent application. Atriva Therapeutics GmbH, Ab&b Bio-Tech Co., Ltd., Emergex Vaccines Holding Ltd. are active in this area.
Baden-Württemberg, Germany
Patent: 30
Jiangsu Sheng, China
Patent: 10
Emergex Vaccines Holding Ltd.
Institut National de la Santé et de la Recherche Médicale
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 5
Lansion Biotechnology Co. Ltd.
Jiangsu Sheng, China
Patent: 3
Colorado, United States
Patent: 3
With the analysis among related 3,701 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Janssen Vaccines & Prevention BV, Regeneron Pharmaceuticals, Inc., Medicago, Inc. take 4.65% of patent filing during this period.
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 63
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 55
Wisconsin, United States
Patent: 43
Wisconsin Alumni Research Foundation
Wisconsin, United States
Patent: 40
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 40
Washington, United States
Patent: 38
Osaka-fu, Japan
Patent: 35
Cidara Therapeutics, Inc.
California, United States
Patent: 33
Ticino, Switzerland
Patent: 33
With the analysis among related 3,701 patents in last 5 years, we discover 328 new entrants. Cidara Therapeutics, Inc., DeTect, Inc., Pontificia Universidad Católica de Chile are the most active new entrants in this area.
Cidara Therapeutics, Inc.
California, United States
Patent: 33
Pontificia Universidad Católica de Chile
Academy of Military Medical Sciences
First Affiliated Hospital of Zhejiang University School of Medicine
undefined undefined
Patent: 16
California, United States
Patent: 16
Nanjing Zenshine Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 15
Hunan Sheng, China
Patent: 14
Jiangxi Caishi Pharmaceutical Technology Co., Ltd.
Jiangxi Sheng, China
Patent: 14
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 13
With the analysis among 1,800 patents, we discovered top 222 universities and scientific research institutions by total patent application. Icahn School of Medicine at Mount Sinai, Yangzhou University, University of Rochester are dominant in this area. They take 11.61% of the total patent filing.
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 75
Jiangsu Sheng, China
Patent: 33
New York, United States
Patent: 27
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 26
Institute of Microbiology
Georgia, United States
Patent: 25
Pontificia Universidad Católica de Chile
South China Agricultural University
Guangdong Sheng, China
Patent: 22
Hubei Sheng, China
Patent: 21
Hunan Sheng, China
Patent: 18